Zimmer Biomet’s move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive , said TheStreet’s Jim Cramer. Zimmer Biomet announced Tuesday that it has agreed to buy LDR Holding for roughly $1 billion. Zimmer offered $37 a share for each of the medical-device company’s shares outstanding, a 64 percent premium to Monday’s close. The deal is expected to close in the third quarter. Cramer said NuVasive is ‘the obvious play so go buy it.’
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
